Induction to efficient treatment
OtherInformative letters.
NCT Number: NCT00882934
Placebo-controlled randomized clinical trials (RCT) are the gold standard to provide applicable evidence for clinical practice. A vast number of RCTs for treatment of several disorders has shown a mean placebo effect of 30%. Erectile dysfunction (ED) is a high prevalent disease and its first-line therapy is oral phosphodiesterase type-5 inhibitor (iPDE5) (i.e., sildenafil, vardenafil and tadalafil). Although the placebo effect in iPDE5 RCT occurred at a rate as high as 50%, in the last decade, with the revolutionary discovery of effective pharmacotherapy for ED, oral iPDE5 has become one of the most common prescribed drugs for men. The objective of this study is to evaluate the influence of patients' awareness on the composition of the therapeutic drug in the outcomes of the oral treatment for ED.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Informative letters.
Informative letters.
Informative letters
Time frame: 4 AND 8 Weeks
Time frame: 4 and 8 weeks
Time frame: 4 and 8 weeks
Time frame: 4 and 8 weeks
Time frame: 4 and 8 weeks
Time frame: 4 and 8 weeks
Rio de Janeiro State University
Other
A Single-Blind, Controlled, Randomized, Parallel-Group Study of the Efficacy of Patients' Awareness on the Composition of the Experimental Drug in the Treatment of Erectile Dysfunction.
Acronym: DAFA06
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01383018
Erectile Dysfunction, Genital Diseases
Homewood, Alabama, United States
View Trial DetailsNCT00654082
Central Nervous System Diseases, Erectile Dysfunction
Bahçelievler, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT00422578
Erectile Dysfunction, Genital Diseases
Tampere, Finland
View Trial DetailsNCT03830164
Erectile Dysfunction, Erectile Dysfunction, CTCAE
Houston, Texas, United States
View Trial Details